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Non-Cognitive Predictors of Student Success:
A Predictive Validity Comparison Between Domestic and International Students
Using machine learning 
techniques, recent ACS or 
ischemic stroke plus hypertension
predicted very high-risk status                    
in 96% and 95% of ASCVD 
patients, respectively
• The 2018 AHA/ACC Blood Cholesterol Guideline 
recommendation to classify ASCVD patients as very high-
risk (VHR) vs. not-VHR (NVHR) has important treatment 
implications1
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Background
Objective
• Develop a simple tool to assist clinicians in identifying VHR 
patients based on machine learning (ML) techniques
Methods
• Retrospective cohort analysis of ASCVD patients in the 
Providence St. Joseph Health (PSJH) system (28 
hospitals) in 2018
• ICD-10 codes derived from the EHR were used to define 
the population
• VHR was defined by ≥2 major ASCVD events or 1 major 
ASCVD event and ≥2 high-risk conditions; patients not 
meeting these criteria were classified as NVHR (Table 1)
• Classification and regression tree (CART) modeling were 
performed on training (n=90,334) and validation 
(n=90,335) datasets, with results compared with a random 
forest model
• Variables in the models included age, sex, race, ethnicity, 
and each of the VHR criteria defined above
• The primary outcome for both models was VHR status
• ML methods employed to predict VHR status can simplify 
clinical decision making at the point of care
Results
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Age, yrs 72 ± 13 73 ± 12 70 ± 13
Male 99365 (55) 57769 (55) 41596 (54)
White 152925 (92) 87096 (91) 65829 (93)
Major ASCVD 
events
Recent ACS* 51111 (28) 49143 (47) 1968 (3) 96
History of MI† 40444 (22) 40186 (39) 258 (0.3) 99
History of 
ischemic stroke
49305 (27) 43117 (41) 6188 (8) 87
Symptomatic 
PAD
30010 (17) 27707 (27) 2303 (3) 92
High-risk
conditions
Age ≥65 years 134391 (74) 81951 (79) 52440 (69) 61
HeFH 3840 (2.1) 2477 (2.4) 1363 (1.8) 65
Prior PCI or 
CABG
23181 (13) 14680 (14) 8501 (11) 63
Diabetes 61293 (34) 40747 (39) 20546 (27) 66
Hypertension 145677 (81) 92205 (89) 53472 (70) 63
CKD 3572 (2.0) 2321 (2.2) 1251 (1.6) 65
Current smoker 59016 (33) 38566 (37) 20450 (27) 65
Persistently 
elevated LDL-C
1566 (0.9) 1000 (1.0) 566 (0.7) 64
History of CHF 42694 (24) 30199 (29) 12495 (16) 71
Table 1: Very High Risk and Not Very High 
Risk Characterization
Data presented as n (%) or mean ± SD
*Within 12 months 
†Outside the ACS event
ACS = acute coronary syndrome, ASCVD = atherosclerotic cardiovascular disease, 
CABG = coronary artery bypass graft, CHF = congestive heart failure, CKD = 
chronic kidney disease, HeFH = heterozygous familial hypercholesterolemia, LDL-C 
= low-density lipoprotein cholesterol, MI = myocardial infarction, PAD = peripheral 
artery disease, PCI = percutaneous coronary intervention, VHR = very high-risk
Conclusions
• Of 180,669 ASCVD patients identified, 104,123 (58%) 
were VHR and 76,546 (42%) were NVHR
• CART and random forest models identified recent ACS, 
ischemic stroke, hypertension, PAD, and history of MI as 
the top five predictors of VHR status
• The CART model’s misclassification rate was 4.3%; AUC 
for the CART and random forest models was 0.949 and 
0.968, respectively
